Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hwangryunhaedoktang in adult atopic dermatitis
ISRCTN26218532Phase 3Completed
- Sponsor
- Korea Health Industry Development Institute
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in atopic dermatitis (AD) comparing Hwangryunhaedoktang with Placebo (2 arms). Primary endpoints: SCORing Atopic Dermatitis index (SCORAD) at 8 weeks, Complete blood cell count at 8 weeks and 5 more. Started Jun 2010; status: completed.
02
Drugs
hwangryunhaedoktang
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on ISRCTN26218532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN26218532.